Spirovant Sciences Patents – Insights & Stats (Updated 2024)

Spirovant Sciences has a total of 37 patents globally, out of which no patents have been granted. Of these 37 patents, more than 89% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Spirovant Sciences.

Spirovant Sciences was founded in the year 2016. The Company is developing novel gene therapies for cystic fibrosis and other pulmonary diseases.

Do read about some of the most popular patents of Spirovant Sciences which have been covered by us in this article and also you can find Spirovant Sciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Spirovant Sciences patent portfolio.

How many patents does Spirovant Sciences have?

Spirovant Sciences has a total of 37 patents globally. These patents belong to 8 unique patent families. Out of 37 patents, 33 patents are active.

How Many Patents did Spirovant Sciences File Every Year?

Spirovant Sciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSpirovant Sciences Applications FiledSpirovant Sciences Patents Granted
20232
20226
20215
202022

How many Spirovant Sciences patents are Alive/Dead?

Spirovant Sciences Patent Portfolio

How Many Patents did Spirovant Sciences File in Different Countries?

Spirovant Sciences Worldwide Patent Filing

 Countries in which Spirovant Sciences Filed Patents

CountryPatents
Israel3
United States Of America3
Australia3
Brazil3
Canada3
Japan3
Europe2
Indonesia2
Singapore2
Mexico2
Viet Nam2
New Zealand2
Hong Kong (S.A.R.)2
Philippines2

Where are Research Centres of Spirovant Sciences Patents Located?

R&D Centers of Spirovant Sciences

What Percentage of Spirovant Sciences US Patent Applications were Granted?

Spirovant Sciences (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Spirovant Sciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Spirovant Sciences?

Law FirmTotal ApplicationsSuccess Rate
Schwegman Lundberg & Woessner10%

List of Spirovant Sciences Patents

Spirovant Sciences PatentsTitle
US20230242941A1Methods And Compositions For Administering Recombinant Viral Vectors
US20220241436A1Compositions And Methods For Treatment Of Cystic Fibrosis
US20220195461A1Methods And Compositions For Transgene Expression
EP3955971A1Compositions And Methods For Treatment Of Cystic Fibrosis
EP3955970A1Methods And Compositions For Transgene Expression
BR112023021377A2Methods And Compositions For Treatment Of Cystic Fibrosis
AU2022256510A9Methods And Compositions For Treatment Of Cystic Fibrosis
IL307709AMethods And Compositions For Treatment Of Cystic Fibrosis
JP2023126658A5Methods And Compositions For Transgene Expression
JP2022529457A5Compositions And Methods For The Treatment Of Cystic Fibrosis
CA3216495A1Methods And Compositions For Treatment Of Cystic Fibrosis
BR112021020706A2Methods And Compositions For Transgene Expression
BR112021020708A2Compositions And Methods For Treatment Of Cystic Fibrosis
AU2020260076A1Compositions And Methods For Treatment Of Cystic Fibrosis
AU2020257182A1Methods And Compositions For Transgene Expression
IL287260ACompositions And Methods For Treatment Of Cystic Fibrosis
IL287262AMethods And Compositions For Transgene Expression
CA3137078A1Methods And Compositions For Transgene Expression
CA3137015A1Compositions And Methods For Treatment Of Cystic Fibrosis
VN92403AMethods And Products For Transfer Genes Expression
VN92404AProducts And Treatment Methods Of Cystic Fibrosis
HK40068813ACompositions And Methods For Treatment Of Cystic Fibrosis
HK40068814AMethods And Compositions For Transgene Expression
PH12021552610A1Compositions And Methods For Treatment Of Cystic Fibrosis
PH12021552609A1Methods And Compositions For Transgene Expression
MX2021012681ACompositions And Methods For Treatment Of Cystic Fibrosis.
MX2021012682AMethods And Compositions For Transgene Expression.
ID202201557AComposition And Methods For The Treatment Of Systic Fibrosis
ID202201556AMethod And Composition For Transgen Expression
SG11202111334SACompositions And Methods For Treatment Of Cystic Fibrosis
SG11202111353QAMethods And Compositions For Transgene Expression
NZ782151AMethods And Compositions For Transgene Expression
NZ782149ACompositions And Methods For Treatment Of Cystic Fibrosis
WO2022221684A1Methods And Compositions For Treatment Of Cystic Fibrosis
JP2022529470AMethods And Compositions For Transgene Expression
WO2020214668A1Compositions And Methods For Treatment Of Cystic Fibrosis
WO2020214672A1Methods And Compositions For Transgene Expression

What are Spirovant Sciences key innovation segments?

What Technologies are Covered by Spirovant Sciences?

The chart below distributes patents filed by Spirovant Sciences in different countries on the basis of the technology protected in patents. It also represents the markets where Spirovant Sciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Spirovant Sciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Spirovant Sciences?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.